Prelude Therapeutics Inc - COM (PRLD)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
35.8M
Holdings value Q3 2024
$74M
Value change Q3 2024
+$3.11M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
69
Number of buys Q3 2024
35
Number of sells Q3 2024
-26
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 35.8M $74M +$3.11M $2.07 69
2024 Q2 33.9M $129M -$1.35M $3.81 59
2024 Q1 34.2M $162M -$2.35M $4.74 56
2023 Q4 34.7M $148M -$6.32M $4.27 55
2023 Q3 36.6M $113M +$1.04M $3.09 57
2023 Q2 36.3M $163M +$31.3M $4.50 52
2023 Q1 31.5M $180M +$1.73M $5.70 54
2022 Q4 31.2M $188M -$4.39M $6.04 59
2022 Q3 31.8M $210M -$5.21M $6.61 50
2022 Q2 32.7M $171M -$7.22M $5.22 55
2022 Q1 34.1M $235M -$11M $6.90 65
2021 Q4 35.2M $438M -$27M $12.45 75
2021 Q3 36M $1.12B +$47.3M $31.25 61
2021 Q2 34.5M $987M +$52.9M $28.63 56
2021 Q1 32.5M $1.41B -$96.9M $43.33 60
2020 Q4 34.7M $2.47B +$136M $71.55 51
2020 Q3 33.3M $1B +$1B $30.13 38